News
Archive
VUV Analytics welcomes industry veteran Lou Cheng to the team
Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb
VUV Analytics introduces HYDRA™: A breakthrough Vacuum Ultraviolet Detector for Liquid Chromatography
Novadip appoints Soumya Chandramouli as Chief Financial Officer
San José City Council unanimously approves next phase of San José Airport Connector Project
NorthSea Therapeutics announces publication of positive results from Phase 2b ICONA clinical trial of icosabutate in biopsy-confirmed F1-F3 MASH in Journal of Hepatology
Back To News
May 11, 2021
Vascular Therapies announces clinical results from its Phase 3 randomized multicenter clinical trial
Vascular Therapies, a privately held biotechnology company is developing Sirogen, a proprietary sirolimus formulation for intraoperative local drug delivery to reduce surgical stenosis in blood vessels. Today the company announced clinical results from its Phase 3 clinical trial in which Sirogen showed encouraging AV fistula outcomes in elderly end-stage renal disease patients.